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SYNOPSIS: 
The thesis entitled “Towards the Total Syntheses of Biologically Active Natural 
Products: FR252921,  Amaminol B, (−)-Lardolure and (2R,4R,6R,8R)-2,4,6,8-
Tetramethylundecanoic Acid” has been divided into three chapters. 
• Chapter I:  This chapter is further subdivided into two sections. 
? Section A: This section deals with introduction of immunosuppressant 
and important previous approaches to immunosuppressant FR252921. 
? Section B: This section describes the formal total synthesis of 
immunosuppressant FR252921. 
• Chapter II: This chapter is further subdivided into two sections. 
? Section A: This section brings flavor of some introduction of IMDA 
cycloaddition and its application for earlier synthetic approaches of 
different bicyclo[4.3.0]nonane derivatives. 
? Section B: This section projects the studies towards the synthesis of 
Amaminol B. 
• Chapter III: This chapter is further subdivided into two sections. 
? Section A: This section deals with the iterative strategies for the 
synthesis of different deoxypropionates. 
? Section B: This section describes the total synthesis of (−)-Lardolure and 
(2R,4R,6R,8R)-2,4,6,8-Tetramethylundecanoic Acid using enzymatic 
desymmetrization technique. 
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CHAPTER-I 
Section A: Introduction  
  The immune system is a marvel of nature. It functions through an exotic 
information network which is constantly engaged in imperceptible war against foreign 
invaders like bacteria, viruses, fungi and parasites and is not controlled by any central 
organ. Immunosuppressants, used to prevent rejection of transplanted organs in surgery, 
have played an important role in our understanding of the immune system.  
The success of organ transplantation surgery is based on the miracle drugs, such as 
Cyclosporine A, FK-506, Rapamycin, 506BD etc which triggered important 
developments in transplantation, autoimmunity, and basic immunology. Outstanding 
progress of experimental immunology in gaining more insight into the mechanisms 
controlling an immune response, but learning how to by pass an undesirable immune 
reaction, it still appears that clinical immunosuppression will continue to rely for quite 
some years on a chemotherapeutic strategy using a subtle combination of more selective 
as well as better tolerated immunopharmachologically effective drugs. 
Section B: Formal total synthesis of immunosuppressant FR252921: 
A novel immunosuppressive agent, FR252921 was isolated from the cultured 
broth of a species of Pseudomonas fluorescens No. 408813. It has been seen that 
FR252921 inhibited splenic proliferation stimulated with LPS, insensitive to calcinuerin 
inhibitor. Analysis of transcription activity revealed that FR252921 inhibited activating 
protein-1 (AP-1). Exposures of antigen presenting cells (APC) to FR252921 attenuated 
proliferation supplemented by naïve T cells. Furthermore, FR252921 strongly suppressed 
splenic dendritic cell proliferation stimulated with LPS and anti-CD40 mAb, while it did 
not inhibit purified T cell activation, including CD154 expression and IL-2 production. 
These results suggest that APC is dominant target cell population. The pronounced 
biological activities and challenging structural features of FR252921 attracted the 
attention of organic chemists. As part of our studies on synthesis of natural products with 
biologically interesting activities, we undertook the synthesis of FR252921 (Figure 1).   
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Figure 1. 
Retrosynthetic analysis of FR252921: 
       Our retrosynthetic analysis suggests that FR252921 1, possessing a 19- membered 
ring structure, would be obtained by macrolactonization of the seco-acid A, which is 
divided into three key fragments  B-D. The first amide bond would be formed by the 
combination of trienic ester fragment B and carboxylic acid fragment C, and another 
peptide coupling between amine part of resulting peptide and another acid fragment D 
would install the second amide bond. The first key fragment B of our  synthetic strategy 
was prepared from 1,4-butane diol, while the other fragment C was obtained from (R)-
malic acid and the last fragment D was synthesized from commercially available prenol, 
depicted in (Scheme 1). 
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As described for the synthesis of trienic ester fragment B, we started from 
commercially available 1,4-butane diol 4. Accordingly 1,4-butane diol was mono 
protected as its THP-ether using 3,4-dihydropyran with a catalytic amount of p-TSA in 
anhydrous CH2Cl2 to get 5 with 70% yield .The free hydroxyl functionality of 5 was 
brominated with CBr4-TPP in anhydrous CH2Cl2 to afford 6 in 75% yield . Compound 6 
was coupled with propargyl alcohol using LiNH2 in liquid ammonia to yield the 
acetylenic alcohol 7 (82% yield), which was consecutively subjected to Swern oxidation 
and C-2 Wittig reaction to yield enyne-ester 8 (85% yield over two steps) with (E:Z 
>95:5) selectivity (judged by 1H and 13C NMR of crude mixture) which was easily 
separated by column chromatography. Isomerisation of enyne ester 8 to (E,E,E) triene 
ester 9 (exclusively by 1H and 13CNMR spectroscopy) was achieved in presence of TPP 
and phenol as an effective co-catalyst at 55 oC.  After complete deprotection of the THP-
ether of triene ester 9 by PPTS in ethanol, we got 10 with 95% yield depicted in (scheme 
2). 
 
  
 
 
 
 
 
 
 
Scheme 2. 
But the overall yield was not satisfactory enough to get good yield of the 
macrocycle product so we decided to go for another route from which we got satisfactory 
yield. We started from same starting material 1,4-butane diol, monoprotected as tert-butyl 
di-methyl silyl ether 11 (84%yeild). Subsequent oxidation of the alcohol to the 
corresponding aldehyde 12 and methyl propiolate addition afforded the alkynoate 13 
(75% over two steps). The “allene-type” rearrangement of 13 with TPP gave the diene 14 
in 75% yield. Diene ester 14 was then underwent DIBAL-H reduction to get alcohol 15 in 
95% yield. Consecutive IBX oxidation and C-2 Wittig reaction of alcohol 15 gave us 
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triene ester 16 with excellent (E:E:E) selectivity (as judged by 1H and 13C NMR 
spectroscopy) and excellent yield (92% over two steps). After deprotection of silyl group 
by TBAF we got 10 with better overall yield for same number of steps, as depicted in 
(scheme 3).  
          
 
 
 
 
 
 
 
Scheme 3. 
Now we proceeded for the synthesis of the fragment B with trienic ester 10. 
Firstly, ester 10 was tosylated with triethylamine, tosyl chloride and catalytic amount of 
DMAP in CH2Cl2 and used without any further purification for azide formation by sodim 
azide in DMF at 55 oC to get azide 17 (83% yield for two steps). Staudinger reaction of 
azide delivered crude amine which was Boc protected to furnish the title fragment B in 
95% yield for two steps and 30% overall yield (Scheme 4).  
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 The carboxylic acid fragment C was derived from commercially available (R)-
malic Acid. Following the procedure reported by Seebach, dimethyl malonate 18 
(prepared from malic acid in MeOH and using catalytic amount of BF3.OEt2, under 
refluxing) was alkylated with MeI and LHMDS in THF to give alcohol 19 (80% yield) 
along with its syn diastereomer (diastereoselectivity = 9:1). Reduction of 19 using LiAlH4 
under reflux, provided the triol 20 in excellent yield. The triol 20 was selectively 
protected to give TBS-ether 21 via a dibutyltin ketal intermediate in 70% yield  for three 
steps .The resulting diol 21 was converted to epoxide 22 with NaH and tosyl-imidazole, 
in 88% yield. Regioselective opening of epoxide 22 with NaN3 in DMF at 70 oC for 1 h 
gave azido alcohol 23 in 95% yield. Azido alcohol 23 was sunjected to Staudinger 
reaction and Boc protection consecutively to yield Boc protected amine 24 quantitatively, 
which was completely separable from its minor syn diastereomer. Subsequent  N-O, 
acetonide protection and TBS deprotection of 24 gave 25 and primary alcohol 26 
respectively in 75% yield over two steps. Our targeted acid fragment C was obtained 
from alcohol 26 by  consecutively IBX oxidation of alcohol to corresponding aldehyde 
and transformation of aldehyde to acid by NaClO2, NaH2PO4, in 80% for two steps. 
(Scheme 5 ). 
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With fragment B and C in our hand we tried to obtain β-hydroxy acid fragment D 
which was synthesized from a cheap starting material prenol 27. Firstly, The hydroxyl 
group of prenol 27 was protected as its tert-butyldiphenylsilyl ether 28. Allylic oxidation 
of 28 was done with SeO2 and tert-BuOOH to deliver allylic aldehyde and alcohol (3:2) 
mixture which was converted to complete aldehyde 29 by PCC oxidation in 45% yield 
for two steps. Aldehyde 29 was converted to β-hydroxy ester 30 by Zn-Cu Couple with 
BrCH2CO2Et in THF with 95% yield. Protection of secondary hydroxyl group of 30 with 
TBS ether gave 31 and selective deprotection of primary TBDPS group with NH4F 
yielded primary alcohol 32 in 95% yield for two steps. Compound 33 was obtained from 
IBX oxidation of primary alcohol 32 which was directly used for Julia olefination with C-
8 sulfone 34 to construct conjugated trisubstituted diene 36 with 70% yield. Deprotection 
of secondary silyl ether 36 by TBAF furnished racemic 37 in 95% yield. The resolution 
of racemic 37 was attempted in three different ways. Carrot reduction of the keto (which 
was obtained from IBX oxidation of 37) gave negative result .Then Sharpless asymmetric 
resolution of secondary alcohol also gave very poor yield, later lipase resolution of 
secondary alcohol resulted into good yield (Scheme 6).    
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Among several lipases and solvent system screened for this resolution, Amano 
lipase PS-C and hexane solvent in presence of vinyl acetate gave satisfactory yield (45%) 
and enantiomeric excess (92%, determined by chiral HPLC). The enantio-enriched 
acetate 38 was the desired (R)-configured confirmed after careful acetyl deprotetion and 
transesterification of 38 in K2CO3/MeOH at −10 oC, to get β-hydroxy methylester (R)-39 
whose optical rotation and spectral data were in full agreement with those previously 
reported by Jannine Cossy et al. The final β- hydroxyl acid fragment D was derived from 
ester hydrolysis with LiOH in THF:MeOH:H2O (2:2:1) and used for next step without 
any further purification which is depicted in (Scheme 7).    
 
 
 
 
 
Scheme 7. 
Now the stage is well set for the coupling of three fragments B, C, D, and we start 
with trienic ester fragment B and carboxylic acid fragment C. After complete 
deprotection of Boc group in presence of TFA in CH2Cl2 (30%) the free amine of trienic 
ester fragment B was coupled with carboxylic acid fragment C using EDCI, HOBt in 
CH2Cl2  to give peptide 40 in 95% yield over two steps. Boc and acetonide group of 
compound 40 was then deprotected by TFA in MeOH:CH2Cl2 (40%) at room temperature 
produces free hydroxy amine. Without any further purifiacation it was coupled with β-
hydroxy acid fragment D in presence of HBTU, HOBt in acetonitrile  to obtain bis-amide 
41 in 90% yield over two steps. Hydrolysis of bis-amide 41 produces seco acid A in 
quantitative yield. Among the several methods, only MNBA proved to be little effective 
to produce tittle compound 1, but we were unable to purify it .We are looking for 
alternate routes (eg. macrolactamisation) to sort out the problem in our lab (Scheme 8).   
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Scheme 8. 
In conclution we have designed a macrocyclisation path to construct the natural 
product FR252921. The methodology described here is applicable for the synthesis of 
other series of molecules of this family, as well as other cyclic depsipeptides. Although, 
we got very poor result for the crucial macrolactonisation reaction, after trying several 
methods, as mentioned earlier, attributed to an inherent structural feature of the 
cyclisation intermediate, which possibly could not attain the required conformation for 
ester bond formation due to the presence of consecutive double bonds.  
CHAPTER-II 
Section A:   Introduction of IMDA Cycloaddition and its application for earlier 
synthetic approaches of different bicyclo[4.3.0]nonane derivatives. 
   
IMDA cycloaddition is undoubtedly the most universal approach to prepare 
bicyclo[4.3.0]nonane containing natural compounds. The preparation methods of 
bicyclo[4.3.0]nonane structures can be divided roughly into thermal IMDA, Lewis acid 
promoted IMDA, chiral auxiliary induced IMDA and other cycloadditions. Diels-Alder 
reaction is assumed to follow a concerted mechanism. IMDA reactions may be divided 
into two categories based on the point of connection of the diene to the dienophile. In the 
type I reactions, the connecting chain is in the terminus of the diene. The IMDA of E-
dienes may produce trans- and cis-fused cycloadducts. If the chain connecting the diene 
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and dienophile is short (less than four carbons), a bridged product is not possible. Z-
Dienes with three or four atoms in the connecting chain produce only cis-fused products.  
Type II IMDA includes a tethered dienophile connected to one of the internal diene 
positions. Type II reaction may produce both syn- or anti-products. It is not surprising 
that several methods for preparing bicyclo[4.3.0]nonane derivatives have been developed. 
This is thanks to the wide variety of interesting compounds, which include the 
bicyclo[4.3.0]nonane substructure or can be derived from a bicyclo[4.3.0]nonane 
derivative. 
Section B: Studies towards the synthesis of Amaminol B. 
Amaminols are cytotoxic against P388 murine leukemia cells isolated in 1999 
from an unidentified  tunicate of the family Polyclinidae, with an IC50 value of 2.1 
µg/mL.Their mode of action is unknown, but they are structurally closely related to 
aliphatic cytotoxic aminoalcohols such as sphingosines, xestoaminols, halaminols, 
leucettamols, crucigasterins, and obscuraminols. Amaminol A (44) and B (45) contains 
an interesting trans-fused hexahydroindene substructure (Figure 2), which has most 
likely been formed by an intramolecular Diels-Alder reaction from a triene in nature.  
 
 
 
Figure 2. 
 Retrosynthetic analysis of Amaminol B 
Retrosynthetic analysis reveals a route based on three consecutive olefinations  by 
Julia-Kocienski olefination and Horner-Wadsworth-Emmons olefination. The stereogenic 
center at C2 and C3 were envisaged to be formed through Sharpless asymmetric 
epoxidation and controlled regioselecitve opening of epoxide to form desired amino 
alcohol. The rest of the stereocenters of 48 were to be formed in an intramolecular Diels-
Alder reaction of inverse electron demand of the intermediate ester 64 through 63. 
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Obvious disconnections of 64 leads to benzyl protected sulfone 50, and TBS protected 
aldehyde 51 (Scheme 9). 
 
 
 
 
 
 
 
Scheme 9. 
 Sulfone 50 and aldehyde 51, which were the main key materials for construction 
of intermediate ester 64, synthesized from 1,4-butane diol and 1,5-pentane diol 
respectively. Monobezyl protection of 1,4-butane diol was done to obtain 52 and 
conversion of another hydroxyl of 52 to sulfide 53 was achieved in the next step under 
Mitsunobu conditions (marcaptobenzothoizole, TPP, DEAD, in dry THF). Sulfide 53 was 
then oxidized by mCPBA in CH2Cl2 to afford sulfone 50 in 57% yield for three steps. 
1,5-Pentane diol was first monoprotected as its tert-butyl dimethylsilyl (TBS) ether  54 
and then another hydroxyl group was oxidized by PCC to obtain aldehyde 51 in 56% 
yield over two steps (Scheme 10). 
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Now with sulfone 50 and aldehyde 51 in our hand, we went for  Julia-Kocienski 
olefination. The sulfone 50 and aldehyde 51 were mixed and cooled at –78 oC in THF, 
and 0.5 M KHMDS was added to get the Julia-Kocienski olefination product 55 in 65% 
yield. Deprotection of  TBS-ether of 55 was done by TBAF to obtain primary alcohol 65 
in 95% yield. Oxidation of alcohol 65 with IBX yielded the corresponding aldehyde 
which in turn subsequently went through Horner-Wadsworth-Emmons olefination 
reaction with the known phosphonate in presence of 1 M LiHMDS to produce our desired 
trienic ester 64 in 77% yield over two steps (Scheme 11). 
 
 
 
 
Scheme 11. 
The trienic ester  64 on heating at 180 oC in toluene with catalytic amount of BHT 
for 2 days in a sealed tube underwent  intramolecular Diels-Alder cyclization to afford 
63, the fused five and six membered ring of Amaminol skeleton in 72% yield with an 
endo/exo diastereomeric ratio of 70:30 (determined by wt. % and chromatographic 
separation). (Scheme 12).  
 
 
Scheme 12. 
The required endo-Diels-Alder Compound 63 was in our hand and we decided 
first to construct the amino alcohol part. For this reason, ester 63 was reduced to alcohol 
66 by DIBAL-H in 94% yield and then protected as tert-butyl diphenylsilyl (TBDPS) 
ether 67 in 90% yield. Compound 67 was treated with AD-mix alpha and methane 
sulphonamide in tert-butanol:H2O (1:1) at 0 oC to afford the desired diol 68 in 85% yield 
and was used for NMR study to confirm the stereochemistry.  The strong nOe 
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correlations between C5H/C11H, C5H/C10H, C5H/C13H, C5H/C13H, C4H/C9H, C2H/C12H  
provides the clear cut evidence for the structure and the energy minimized structure as 
shown in (Scheme 13) was also agreement with assigned structure from the NMR data. 
 
 
 
 
 
 
 
Scheme 13. 
Benzyl deprotection of 67 by lithium/naphthalene at −20 oC in THF, yielded 
alcohol 69 in 96% yield, which was oxidized to aldehyde with IBX/DMSO and 
subsequently underwent C-2 Wittig reaction in CH2Cl2 to provide the α,β-unsaturated 
ester compound 70 in 77% yield over two steps. The chemoselective reduction of α,β-
unsaturated ester 70 with DIBAL-H was achieved at −78 oC to afford the allyl alcohol 71 
in 95% yield (Scheme 14). 
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Allylic alcohol 71 on Sharpless asymmetric epoxidation using D-(−)-DIPT, 
Ti(OiPr)4 and TBHP in CH2Cl2 yielded epoxy alcohol 72 in 80% yield. Regioselective 
epoxide opening of 72 with sodium azide and trimethyl borate at 50 oC afforded 1,3-diol 
73 (minor 1,2 diol was separated by periodate oxidation) in 66% yield over two steps. 
Primary alcohol 73 was tosyl protected by pTsCl and Et3N, in CH2Cl2 and without any 
further purification it was reduced by LiAlH4 in THF to get amino alcohol, which was 
protected as its Boc derivative by (Boc)2O, Et3N, in THF to obtain desired Boc-amino 
alcohol 74 in 52% yield over three steps. N,O-Acetonide protection and primary silyl 
group deprotection  of compound 74 was achieved simultaneously by 2,2-DMP and 
catalytic amount of CSA (camphorsulfonic acid) in MeOH:CH2Cl2 (1:1) solvent system 
to afford primary alcohol 75 in 71% yield (Scheme 15).  
 
 
 
 
 
 
 
 
 
 
Scheme15. 
Finally, DMP (Dess Martin Periodinane) oxidation of alcohol 75 in CH2Cl2 at 0 oC 
afforded corresponding aldehyde which was found to be very unstable and immediately 
used for  Julia olefination reaction with C-3 sulfone 76. Unfortunately no product was 
isolated due to immediate decomposition of aldehyde. Different purification techniques 
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were used to solve this problem and it is an ongoing process in our lab to come with a 
fruitful result. 
In conclusion, we have designed a new approach towards the total synthesis of 
(+/−) Amaminol B by using Diels-Alder reaction with inverse electron demand as the key 
step. Other reactions involved are Julia olefination, HWE olefination, and regioselective 
ring opening reactions.  
 
CHAPTER-III 
Section A: Iterative strategies for the synthesis of   different deoxypropionates. 
Polypropionates (polyketides) are synthesized in nature by the polymerization of 
propionyl subunits via Claisen condensation reactions followed by reduction of the 
resulting keto-function. This results in a continuous methyl-hydroxy-methyl iteration 
with all possible stereoconfigurations, coming in cyclic as well as and acyclic structures. 
However, nature sometimes deviates from the polypropionate pattern by formal removal 
of the hydroxyl group resulting in syn or anti 1,3,5,… n-polymethyl alkyl chains (Figure 
3), the deoxypropionates. Deoxypropionates are the enzymatically dehydrated and 
reduced products of polypropionates and are widely distributed as individual and 
combined structures in natural products. 
 
 
 
 
 
 
Figure 3: The polyketide/propionate structure compared to the related 
deoxypropionate structure. 
Deoxypropionates are synthesized by bacteria, fungi, and plants. Because of the 
abundant presence of deoxypropionate units in natural products, many synthetic 
strategies have been developed over the last three decades. These strategies are often 
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based on the selective introduction of methyl substituents in an consecutive (iterative) 
fashion, either syn or anti, and can be divided in non-catalytic and catalytic strategies. 
Section B: Total synthesis of (−)-Lardolure and (2R,4R,6R,8R)-2,4,6,8-  
                    Tetramethylundecanoic Acid using enzymatic desymmetrization 
                    technique. 
Lardolure (80) is the aggregation pheromone of the acarid mite (Lardoglyphis 
konoi), while (2R,4R,6R,8R)-2,4,6,8-tetramethylundecanoic acid (81) is the acid 
component of the preen-gland wax of the graylag goose (Anser anser) (Figure 4). 
 
 
 
Figure 4. 
The retrosynthetic approach for the targeted  molecules 80 and 81 can easily be 
envisioned from the common allylic alcohol intermediate 87 which has three chiral 
methyl groups. Furthermore, 87 could be obtained from primary alcohol 88, which was 
synthesized from 90 via 89 by using Wittig reaction and Evan’s alkylation reaction. 
Compound 90 on the other hand was prepared from cis-4,6-dimethyl cyclohexan-1,3-
dione 91 in four steps (Scheme 16). 
 
 
 
 
 
 
Scheme 16. 
Our synthesis began with the known precursor 90 that has two chiral centres 
already in place. Compound 90 was synthesized in four steps starting from cis-4,6-
dimethylcyclohexan-1,3-dione 91 following a well-reported protocol. Accordingly, cis-
diketone was converted into the diacid 92  by periodate oxidation in 96% yield. LiAlH4 
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reduction of the diacid 92 in THF at room temperature gave the meso-diol 93 in 97% 
yield. Desymmetrization of meso-diol by using porcine pancreatic lipase (PPL) and vinyl 
acetate in THF at ambient conditions furnished the mono acetate 90 in 47% yield and at 
least 95% ee along with the meso-diacetate. It is noteworthy to mention that the meso-
diacetate obtained was again converted back to the meso-diol by treatment with CH3ONa 
in methanol in quantitative yield for further utililations. Mono acetate 90 in hand was 
protected as its silyl ether using TBSCl and imidazole in dichloromethane and then 
treated with CH3ONa in methanol to furnish the desired terminal alcohol 94 with 96% for 
two steps (Scheme 17). 
 
 
 
 
Scheme 17. 
Subsequently, oxidation of alcohol 94 followed by two-carbon atoms extension 
by means of Wittig reaction gave the α,β-unsaturated ester 95 in 86% yield in overall two 
steps. Reduction of the double bond with NaBH4 in the presence of NiCl2·6H2O in MeOH 
afforded the saturated ester 96 in 96% yield which was then hydrolyzed under basic 
conditions to furnish the corresponding carboxylic acid 97 in 93% yield. Coupling of acid 
97 with the Evan’s chiral oxazolidinone using pivaloyl chloride in presence of 
triethylamine and LiCl furnished the required compound 98 in 93% yield. 
Diastereoselective methylation of the Na-enolate of compound 98 with MeI furnished the 
desired compound 89 in 91% yield and in >97:3 diastereomeric exess,  which was 
confirmed by 1H NMR spectroscopy, and then subjected to reduction by NaBH4 in 
MeOH to obtain the desired primary alcohol 88 having a new additional chiral centre in 
92% yield. (Scheme 18). 
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Scheme 18. 
Alcohol 88 was then tosylated with Et3N, pTsCl, DMAP at 0 oC and subsequently 
reacted with freshly prepared ethyl grignard to furnish  compound 99, in 90% yield for 
two steps. Deprotection of tert-butyl dimethylsilyl (TBS) ether of 99 was done by 1 M 
TBAF in THF at 0 oC to obtain long chain alcohol 100 in 95% yeild, which was then 
oxidized by Swern condition and subsequently underwent Wittig reaction  to yield α,β-
unsaturated  ester 101 in 85% yield for two steps. The α,β-unsaturated  ester 101 was 
reduced by DIBAL-H at −78 oC to the corresponding common allylic alcohol 
intermediate 87 in 95% yield (Scheme 19). 
 
 
   
 
Scheme 19. 
Common allylic alcohol 87 was converted to saturated aldehyde (which was not 
isolated due to volatile) by using Pd(OH)2/C in benzene, the methodology developed by 
our group recently. α-hydroxylation of the aldehyde by D-proline and PhNO in CHCl3 at 
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room temperature and then subsequent breaking of O-N linkage by CuSO4/MeOH 
produces terminal diol 102 in 50% yield for three steps and >99% diastereoselectivity 
(determined by HPLC analysis). Under selectve monotosylation of primary alcohol by p-
TsCl, Et3N, and subsequent treatment with LiAlH4 yielded secondary alcohol 103, in 
82% yield for two steps. Finally alcohol 103 was formylated at 65 oC with formaldehyde 
to produce the desired product (−)-lardolure 80 (Scheme 20). 
 
 
 
 
Scheme 20. 
After successfull completion of synthesis of (−)-lardolure 80, we targeted for 
(2R,4R,6R,8R)-2,4,6,8-tetramethylundecanoic acid 81, which we synthesized from 
common allylic alcohol intermediate 87. Accordingly, the allylic alcohol 87 was 
subjected to Pd-mediated oxidation to saturated aldehyde as mentioned earlier, followed 
by transformation of aldehyde to the corresponding acid 106 under Pinnick conditions 
using NaClO2, NaH2PO4, in tBuOH:H2O (2:1)  with 75% yield in two steps. Coupling of 
acid 106 with the  Evan’s chiral oxazolidinone using pivaloyl chloride in presence of 
triethylamine and LiCl furnished the required compound 107 in 95% yield. 
Diastereoselective methylation of the Na-enolate of compound 107 with MeI furnished 
the desired compound 108 in 91% yield. Finally hydrolysis of 108 with LiOH, H2O2  
yielded (2R,4R,6R,8R)-2,4,6,8-tetramethylundecanoic acid 81 in 91% yield and with >99 
% diastereoselectivity (determined by HPLC analysis). (Scheme 21). 
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Scheme 21. 
In conclusion, we have accomplished  a convergent synthetic protocol for the 
synthesis of two biologically active molecules (−)-lardolure and (2R,4R,6R,8R)-2,4,6,8-
tetramethylundecanoic acid from a common intermediate using enzymatic 
desymmetrization of meso-diol, diastereselective methylation, chiral α-hydroxilation as 
the key steps and the synthesis was achieved in a stereoselective manner. 
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 Introduction 
Cyclodepsipeptides shows an interesting spectrum of biological activity and serve as 
lead compounds for more pharmacologically potent and toxicologically safe derivatives. 
They are characterized by the occurrence of at least one ester linkage. Though a common 
feature of cyclodepsipeptides is their ionophoric properties yet, their pharmacologically 
relevant action does not seem to correlate with this feature and it is based on interactions 
with distinct cellular compartments and signal transduction pathways. It was suggested that 
the cyclic depsipeptide structure is important for the biological activity because the linear 
homologues were inactive. Cyclodepsipeptides, which are currently being evaluated in 
clinical trials, are used in refractory cancer therapy, usually in combination with other 
cytotoxic drugs. A number of cyclodepsipeptides have been well characterized in vitro and 
in vivo, and interesting modes of action, such as immunosuppressant, antibiotic, 
antifungal, antiplasmodial, antiviral, insecticidal, cytotoxic, and antiproliferative properties 
have been observed. Our present discussion deals with the immunosuppressive activity of 
these types of compounds. 
Immune system and Immunology: 
We are surrounded by billions of bacteria and viruses and a human being is like a 
walking smorgasbord among them, offering nearly limitless resources that they can use for 
energy and reproduction. Luckily for us, getting into the human body is not an easy task! 
From the point of view of these tiny organisms, a human is a bit like a fortress. The skin is 
thick and very hard to penetrate which also produces a variety of substances that are 
harmful to invaders. Openings such as the eyes, nose, and mouth are protected by fluids or 
sticky mucus that captures harmful attackers. The respiratory tract also has mechanical 
defences in the form of cilia, tiny hairs that remove particles. Intruders that get as far as the 
stomach are up against a sea of stomach acid that kills most of them. But in spite of our 
fantastic defenses, hostile invaders still manage to get through. Some enter along with our 
food, while others may sneak in via the nose. And, as we all know, many things can break 
through our skin. In everyday life we often receive cuts or scrapes, and every time this 
happens we face the risk of a full-scale invasion from bacteria or viruses. What is the 
magic, then, that keeps us healthy most of the time? 
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When we receive a cut, and when invaders enter the body, cells are destroyed. The dying 
cells trigger an automatic response called inflammation, which includes dilated blood 
vessels and increased blood flow. An inflammation is the body's equivalent to a burglar 
alarm. Once it goes off, it draws defensive cells to the damaged area in great numbers. 
Increased blood flow helps defensive cells to reach the place where they're needed. It also 
accounts for the redness and swelling that occur. The defensive cells are more commonly 
known as immune cells. They are part of a highly effective defence force called the 
immune system. The cells of the immune system work together with different proteins to 
seek out and destroy anything foreign or dangerous that enters our body. It takes some time 
for the immune cells to be activated - but once they're operating at full strength, there are 
very few hostile organisms that stand a chance. Immune system is designed to perform 
several tasks including i) to fight off intruders such as bacteria, viruses and parasites, ii) to 
identify and kill pathogens and tumor cells,1 iii) to clear transformed cells or antibody 
complexes, iv) to heal injured tissues. The immune system is mainly divided into two 
interacting components which are subdivided into several components as follows (Figure 
1).  
 
 
 
 
 
 
 
 
 
 
Figure 1. 
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